Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-04

FDA Approved: PYRIDOSTIGMINE BROMIDE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved pyridostigmine bromide from Amneal Pharmaceuticals under an original application for use in treating myasthenia gravis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyridostigmine bromide (Pyridostigmine bromide)

Snippet

ORIG AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)